870
panel
Recording | ESG Investing Comes of Age
panel
Cancer Didn't Quit During the Pandemic
The bad news: Cancer did not take a break during the COVID-19 pandemic, and thousands of people
had to forego or postpone cancer treatments and care due to the downstream effects of the virus.
+ Read More
panel
How COVID-19 Has Accelerated Patient-Centered Clinical Trial Innovation
The COVID-19 pandemic has ushered in a new era of clinical research by revealing what can be ach
ieved in weeks or months and how drug development can be accelerated. Master trial protocols allow simultaneous study of multiple therapies.
+ Read More
panel
Moving the Needle on Diversity, Equity, and Inclusion in Clinical Research
Details of inequities and lack of diversity in clinical research have been revealed with the COV
ID-19 pandemic.
+ Read More
panel
Emerging Venture Philanthropists Investing for Patient Impact
Venture philanthropy can be narrowly defined as philanthropic capital invested in for-profit ven
tures to achieve both social and financial returns.
+ Read More
panel
The Future of Rare Disease R&D: Protecting Progress, Achieving Access
More than 25 million Americans live with a rare disease.
panel
Partnering for Patients Networking Roundtables (Invite only)
A key driver of innovation in biomedical research is the ability of patient organizations to con
nect and collaborate with fellow patient advocates, researchers, and other leaders in the field.
+ Read More
panel
Health in the 117th Congress
panel